Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms restricting hepatitis B virus cross-species transmission.

mBio·2026
Same author

Metadomain and metaloop genome interactions in mammalian T cells.

Cell reports·2026
Same author

EIF4H and YBX1 are essential host factors for hepatitis E virus replication and pathogenesis.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Metadomain and metaloop genome interactions in mammalian T cells.

bioRxiv : the preprint server for biology·2025
Same author

Receptor transporter protein 4 (RTP4)-mediated repression of hepatitis C virus replication in mouse cells.

PLoS pathogens·2025
Same author

Assessment of hepatitis C virus permissiveness in iteratively genetically humanized mice.

Journal of virology·2025

Related Experiment Video

Updated: Jun 1, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
10:12

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

A genetically humanized mouse model for hepatitis C virus infection.

Marcus Dorner1, Joshua A Horwitz, Justin B Robbins

  • 1Center for the Study of Hepatitis C, The Rockefeller University, New York, New York 10065, USA.

Nature
|June 10, 2011
PubMed
Summary

Researchers created a new mouse model for Hepatitis C virus (HCV) infection by genetically modifying mice. This breakthrough allows for studying HCV in immunocompetent animals, paving the way for new therapies and vaccines.

More Related Videos

Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells
11:44

Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells

Published on: August 29, 2016

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Related Experiment Videos

Last Updated: Jun 1, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
10:12

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells
11:44

Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells

Published on: August 29, 2016

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Area of Science:

  • Virology
  • Immunology
  • Genetics

Background:

  • Hepatitis C virus (HCV) poses a significant global health challenge with limited treatment options and no existing vaccine.
  • The absence of a suitable small animal model has hindered the development of effective therapies.
  • Previous attempts using human hepatocyte xenotransplantation faced notable limitations.

Purpose of the Study:

  • To develop a genetically modified immunocompetent mouse model susceptible to Hepatitis C virus (HCV) infection.
  • To establish a platform for studying HCV pathogenesis and immune responses in vivo.
  • To validate potential therapeutic strategies, including entry inhibitors and immunotherapies.

Main Methods:

  • Genetically engineered mice to express human CD81 and occludin, key factors for HCV entry.
  • Inoculated genetically modified mice with HCV to assess infectivity and viral replication.
  • Utilized passive immunization and a recombinant vaccinia virus vector to evaluate immune responses and protection.
  • Investigated the role of scavenger receptor type B class I (SR-BI) in HCV uptake.

Main Results:

  • Expression of two human genes enabled HCV infection in fully immunocompetent inbred mice.
  • The developed model recapitulates aspects of the HCV life cycle in an immunocompetent rodent.
  • Passive immunization demonstrated the ability to block HCV infection.
  • A recombinant vaccinia virus vector induced humoral immunity and provided partial protection against challenge.

Conclusions:

  • A novel, genetically engineered immunocompetent mouse model for HCV infection has been successfully established.
  • This model offers unprecedented opportunities for in-depth study of HCV pathogenesis and host immunity.
  • The platform is effective for preclinical testing of HCV entry inhibitors and vaccine candidates in vivo.